Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Benign

The reasons Strike wrote this book. The reasons you re reading this book. Ecstasy is the most benign drug Strike has ever encountered. It is passive yet powerful. By powerful Strike does not mean that it incapacitates or makes one dangerous. It is, in fact, quite the opposite. Its power is in its ability to evoke a total sensory bath of tactile, visual and mental enhancement. One s perception is perfectly clear. Hallucinations are nonexistent. The feeling one has is, literally, ecstasy. Plus, it is one of the few narcotics in the world that is not physically addictive. Why this substance was taken away from the people is a question that only government-funded scientists can answer. [Pg.7]

The terms green chemistry and environmentally benign synthesis have been coined to refer to procedures explicitly designed to minimize the for mation of byproducts that present disposal problems Both the National Science Foundation and the Envi ronmental Protection Agency have allocated a por tion of their grant budgets to encourage efforts m this vein... [Pg.644]

There is a curious irony in the nomination of hypochlorite as an environmentally benign oxidizing agent It comes at a time of increasing pressure to eliminate chlorine and chlorine containing com pounds from the environment to as great a degree as possible Any all inclusive assault on chlorine needs to... [Pg.645]

Work on other routes to ceUulosic fibers continues, driven by a desire to identify an environmentally benign route to ceUulosic fibers that can utilize the large capital investment in the xanthate route and hence cost less than a completely new fiber process. [Pg.352]

A D—T fusion reactor is expected to have a tritium inventory of a few kilograms. Tritium is a relatively short-Hved (12.36 year half-life) and benign (beta emitter) radioactive material, and represents a radiological ha2ard many orders of magnitude less than does the fuel inventory in a fission reactor. Clearly, however, fusion reactors must be designed to preclude the accidental release of tritium or any other volatile radioactive material. There is no need to have fissile materials present in a fusion reactor, and relatively simple inspection techniques should suffice to prevent any clandestine breeding of fissile materials, eg, for potential weapons diversion. [Pg.156]

Potential fusion appHcations other than electricity production have received some study. For example, radiation and high temperature heat from a fusion reactor could be used to produce hydrogen by the electrolysis or radiolysis of water, which could be employed in the synthesis of portable chemical fuels for transportation or industrial use. The transmutation of radioactive actinide wastes from fission reactors may also be feasible. This idea would utilize the neutrons from a fusion reactor to convert hazardous isotopes into more benign and easier-to-handle species. The practicaUty of these concepts requires further analysis. [Pg.156]

It is not appropriate to generali2e the carcinogenicity of this class of compounds. Nitrofura2one appears to increase the incidence of benign mammary tumors in rats. The tumorigenic activity of fura2ohdone is expressed by an increase in the incidence of spontaneous tumors in both mice and rats. Bioassays of nitrofurantoin in several species of mice and rats failed to reveal any evidence of direct tumorigenic activity. Ovarian tumors have been reported in B C F mice, but these are beheved due to an indirect expression of toxicity (14,15). [Pg.460]

Nuclear medicine studies may reveal information that is primarily anatomic in nature, or indicate the function of an organ on a regional basis (Table 1). These studies may be intended to identify new disease, confirm or deny suspected disease, or foUow the progress of treatment or the course of disease. The diseases may be relatively benign or extremely serious and can range from widespread medical problems such as ischemic heart disease to rarities such as Legge-Perthe s disease and malignant pheochromocytoma (7). [Pg.474]

As CFG refrigerants are phased out of production, their replacements in the cold storage appHcations will be HFC candidates such as R-134a, R-404A, and R-507. The use of ammonia, which is considered an environmentally benign refrigerant, will continue to play an ever-increasing role. [Pg.64]

Zeolite-Based All lation. Zeohtes have the obvious advantages of being noncorrosive and environmentally benign. They have been extensively researched as catalysts for ethylbenzene synthesis. Eadier efforts were unsuccessful because the catalysts did not have sufficient selectivity and activity and were susceptible to rapid coke formation and deactivation. [Pg.478]

The inorganic tin compound that has received the most study from a toxicological viewpoint is stannic oxide. Autopsies performed on workers in the tin mining and refining industry, who inhaled tin oxide dust for as long as 20 yr, disclosed no pulmonary fibrosis (57). Inhalation for long periods produces a benign, symptomless pneumoconiosis with no toxic systemic effects (58). [Pg.67]


See other pages where Benign is mentioned: [Pg.40]    [Pg.2697]    [Pg.2804]    [Pg.134]    [Pg.644]    [Pg.98]    [Pg.289]    [Pg.312]    [Pg.150]    [Pg.155]    [Pg.199]    [Pg.199]    [Pg.199]    [Pg.262]    [Pg.279]    [Pg.421]    [Pg.223]    [Pg.223]    [Pg.245]    [Pg.370]    [Pg.453]    [Pg.478]    [Pg.103]    [Pg.397]    [Pg.48]    [Pg.288]    [Pg.148]    [Pg.472]    [Pg.427]    [Pg.516]    [Pg.64]    [Pg.232]    [Pg.417]    [Pg.444]    [Pg.447]    [Pg.447]    [Pg.227]    [Pg.228]    [Pg.235]   
See also in sourсe #XX -- [ Pg.133 ]

See also in sourсe #XX -- [ Pg.146 , Pg.268 ]

See also in sourсe #XX -- [ Pg.11 ]

See also in sourсe #XX -- [ Pg.61 , Pg.188 , Pg.319 , Pg.321 , Pg.334 ]

See also in sourсe #XX -- [ Pg.98 , Pg.99 ]

See also in sourсe #XX -- [ Pg.133 ]

See also in sourсe #XX -- [ Pg.246 ]

See also in sourсe #XX -- [ Pg.81 ]

See also in sourсe #XX -- [ Pg.340 ]

See also in sourсe #XX -- [ Pg.382 , Pg.441 , Pg.740 , Pg.767 , Pg.905 , Pg.1362 , Pg.1374 ]




SEARCH



A Client with Benign Prostatic Hypertrophy and Spinal Anesthesia

Adhesiveness benign cells

Adhesiveness of Benign Cells

Alcohol environmentally benign oxidant

Alternative solvents benign solvent substitutes

Antiandrogens benign prostatic hyperplasia

Appetite benign

BPH (benign prostatic

Benign Imaging

Benign Liver Lesions

Benign Report

Benign alternatives development

Benign and Malignant Tumors

Benign and Malignant Tumors in Mammals

Benign by design

Benign by design chemistry

Benign catalysis, environmentally, green

Benign catalysis, environmentally, green chemistry research

Benign categorization

Benign cephalic histiocytosis

Benign chemical

Benign childhood epilepsy with centrotemporal

Benign childhood epilepsy with centrotemporal spikes

Benign classification

Benign defining term

Benign essential blepharospasm

Benign failure

Benign familial neonatal convulsions

Benign familial recurrent cholestasis

Benign fasciculations

Benign gastric ulceration

Benign granuloma

Benign intracranial

Benign intracranial hypertension

Benign mass

Benign neonatal epilepsy

Benign neoplasm

Benign ocular burns

Benign oligemia

Benign osteoid osteoma

Benign ovarian neoplasm

Benign peripheral nerve sheath tumors

Benign pleural disease

Benign proliferative epithelial

Benign proliferative epithelial disorders

Benign prostate hyperplasia

Benign prostate hypertrophy

Benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH

Benign prostatic hyperplasia combination therapy

Benign prostatic hyperplasia complications

Benign prostatic hyperplasia diagnosis

Benign prostatic hyperplasia epidemiology

Benign prostatic hyperplasia evaluation

Benign prostatic hyperplasia finasteride

Benign prostatic hyperplasia lower urinary tract symptoms

Benign prostatic hyperplasia medications

Benign prostatic hyperplasia obstructive symptoms

Benign prostatic hyperplasia phytotherapy

Benign prostatic hyperplasia prostate-specific antigen

Benign prostatic hyperplasia prostatectomy

Benign prostatic hyperplasia severity

Benign prostatic hyperplasia surgery

Benign prostatic hyperplasia surgical

Benign prostatic hyperplasia treatment

Benign prostatic hyperplasia urinary incontinence

Benign prostatic hyperplasia, permixon

Benign prostatic hyperplasia, treatment finasteride

Benign prostatic hypertrophy

Benign proteinuria

Benign recurrent cholestasi

Benign shock

Benign soft-tissue tumors

Benign solvent

Benign symmetric lipomatosis

Benign thyroid disease

Benign thyroid disease treatment

Benign tumours

Benign waste

Benign waste streams

Benignity concept

Beyond Benign

Cancer benign tumors

Carbon dioxide, supercritical environmentally benign solvent

Catalysts, role in environmentally benign

Catalysts, role in environmentally benign synthesis of chemicals

Cells benign

Cemilton in treatment of benign prostatic

Chemically benign synthesis

Environment benign catalysis

Environmental benign

Environmental questions, benign

Environmentally Benign (Green) Processing

Environmentally benign

Environmentally benign analytical

Environmentally benign analytical techniques

Environmentally benign catalysis

Environmentally benign chemical

Environmentally benign chemistiy

Environmentally benign chemistry

Environmentally benign manufacturing

Environmentally benign media

Environmentally benign production

Environmentally benign production biocatalysts

Environmentally benign production biomass

Environmentally benign production commodity chemicals

Environmentally benign production economics

Environmentally benign production ethanol

Environmentally benign production technology

Environmentally benign solvent substitutes

Environmentally benign synthesis

Ethanol, environmentally benign

Finasteride benign prostatic hypertrophy treatment

Finasteride in benign prostatic hyperplasia

Gastric ulcer, benign

Green Chemistry Benign by Design

Initiatives for benign by design

Initiatives for benign by design chemistry

Isolated enzymes, environmentally benign

Lactic acid, environmentally benign

Lipid metabolism benign symmetric lipomatosis

Liver benign solid lesion

Mesenchymal benign

Minocycline benign intracranial

Modern Oxidation of Alcohols using Environmentally Benign Oxidants

Multiple sclerosis benign

Organic Solvents Environmentally Benign Solutions

Organic-water interface, chemically benign synthesis

Oxidation environmentally benign oxidant

Paradigms benign

Permixon in the Treatment of Symptomatic Benign Prostatic Hyperplasia

Phase-transfer catalysis in environmentally benign reaction media

Proscar, benign prostatic hyperplasia

Prostate benign prostatic hyperplasia

Prostate cancer benign hyperplasia

Prostate gland benign hyperplasia

Prostate prostatic hypertrophy, benign

Prostatic hyperplasia, benign symptoms

Purine benign symmetric lipomatosis

Pygeum africanum and Permixon for the Treatment of Patients with Benign Prostatic Hyperplasia

Reaction media, environmentally benign

Reagents, environmentally benign

Recycling of Benign Waste Streams in CBPC Value-Added Products

Research, benign chemistry

Role in environmentally benign synthesis

Role in environmentally benign synthesis of chemicals

Searching Environmentally Benign Methods for Pest Control Reflections of a Synthetic Chemist

Shock-Compression Paradigms Benign and Catastrophic

Solvents environmentally benign

Synthesis and applications of phosphines in environmentally benign catalysis

Synthesis of Environmentally Benign Species

Toward development of environmentally benign processes

Tumor benign

Ulcer benign

Water benign process technologies

© 2024 chempedia.info